Valion Bio (VBIO) Other financing activities (2021 - 2025)

Valion Bio (VBIO) posted quarterly Other financing activities of $109000.0 for Q1 2025, up 94.64% quarter-over-quarter from $56000.0 in Q3 2021.

Valion Bio (VBIO) Other financing activities (2021 - 2025) Analysis & Trends

Valion Bio's Other financing activities history runs 2 years deep, the most recent figure standing at $109000.0 for Q1 2025.

In Q1 2025, Other financing activities changed N/A year-over-year to $109000.0; the TTM figure through Dec 2025 stood at $109000.0 (changed N/A YoY), while the FY2025 annual figure was $109000.0, changed N/A from the prior year.
Other financing activities for Q1 2025 stood at $109000.0, up from $56000.0 in the prior quarter.
The five-year high for Other financing activities was $109000.0 in Q1 2025, with the low at $6000.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.71 Bn	131.86 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.55 Bn	78.55 Bn	3.93 Bn
3	Argenx Se	65.26 Bn	60.07 Bn	1.37 Bn
4	Moderna	59.81 Bn	54.67 Bn	52.00 Mn
5	BeOne Medicines	42.16 Bn	37.06 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.87 Bn	28.56 Bn	992.69 Mn
7	BioNTech SE	28.13 Bn	9.74 Bn	668.28 Mn
8	Insmed	27.53 Bn	26.37 Bn	358.27 Mn
9	Royalty Pharma	27.31 Bn	26.47 Bn	-
10	Valion Bio	410,331.63	-1.79 Mn	-45,000.00

Download Data